Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
2014 · Journal of Thoracic Oncology · 45 citations
https://doi.org/10.1097/jto.0000000000000365
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
1.8K
Citations
13
h-index
13
i10-index
Anne-Renee Hartman is an academic researcher from Gilead Sciences (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & DNA Repair Mechanisms & BRCA gene mutations in cancer. The author has an h-index of 13, co-authored 13 publications.
https://doi.org/10.1097/jto.0000000000000365
https://doi.org/10.1186/bcr1663
Click to start Chat